Trials / Completed
CompletedNCT01241331
BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
A Randomized, Controlled Evaluation of the Safety and Efficacy of a Topical Treatment for Moderate-Severe Facial Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 233 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 12 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of formulation BLI1100 to its vehicle in the treatment of moderate-severe acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI1100 | BLI110 topical cream |
| DRUG | Vehicle cream | Vehicle topical cream |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-04-01
- First posted
- 2010-11-16
- Last updated
- 2012-10-01
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01241331. Inclusion in this directory is not an endorsement.